Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Relationship between pore size and velocity probability distributions in stochastically generated porous media.

Siena M, Riva M, Hyman JD, Winter CL, Guadagnini A.

Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Jan;89(1):013018. Epub 2014 Jan 23.

PMID:
24580331
2.

Hyperbolic regions in flows through three-dimensional pore structures.

Hyman JD, Winter CL.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Dec;88(6):063014. Epub 2013 Dec 19.

PMID:
24483564
3.

Heterogeneities of flow in stochastically generated porous media.

Hyman JD, Smolarkiewicz PK, Winter CL.

Phys Rev E Stat Nonlin Soft Matter Phys. 2012 Nov;86(5 Pt 2):056701. Epub 2012 Nov 1.

PMID:
23214900
4.

Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials.

Popplewell LJ, Adkin C, Arechavala-Gomeza V, Aartsma-Rus A, de Winter CL, Wilton SD, Morgan JE, Muntoni F, Graham IR, Dickson G.

Neuromuscul Disord. 2010 Feb;20(2):102-10. doi: 10.1016/j.nmd.2009.10.013. Epub 2010 Jan 15.

PMID:
20079639
5.

Development of antisense-mediated exon skipping as a treatment for duchenne muscular dystrophy.

Heemskerk H, de Winter CL, van Ommen GJ, van Deutekom JC, Aartsma-Rus A.

Ann N Y Acad Sci. 2009 Sep;1175:71-9. doi: 10.1111/j.1749-6632.2009.04973.x.

PMID:
19796079
6.

In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.

Heemskerk HA, de Winter CL, de Kimpe SJ, van Kuik-Romeijn P, Heuvelmans N, Platenburg GJ, van Ommen GJ, van Deutekom JC, Aartsma-Rus A.

J Gene Med. 2009 Mar;11(3):257-66. doi: 10.1002/jgm.1288.

PMID:
19140108
7.

Assessment of the feasibility of exon 45-55 multiexon skipping for Duchenne muscular dystrophy.

van Vliet L, de Winter CL, van Deutekom JC, van Ommen GJ, Aartsma-Rus A.

BMC Med Genet. 2008 Dec 1;9:105. doi: 10.1186/1471-2350-9-105.

8.

Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanisms.

Aartsma-Rus A, van Vliet L, Hirschi M, Janson AA, Heemskerk H, de Winter CL, de Kimpe S, van Deutekom JC, 't Hoen PA, van Ommen GJ.

Mol Ther. 2009 Mar;17(3):548-53. doi: 10.1038/mt.2008.205. Epub 2008 Sep 23.

9.

Therapeutic modulation of DMD splicing by blocking exonic splicing enhancer sites with antisense oligonucleotides.

Aartsma-Rus A, Janson AA, Heemskerk JA, De Winter CL, Van Ommen GJ, Van Deutekom JC.

Ann N Y Acad Sci. 2006 Oct;1082:74-6.

PMID:
17145928
10.

Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: indication for steric hindrance of SR protein binding sites.

Aartsma-Rus A, De Winter CL, Janson AA, Kaman WE, Van Ommen GJ, Den Dunnen JT, Van Deutekom JC.

Oligonucleotides. 2005 Dec;15(4):284-97.

PMID:
16396622
11.

A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats.

Winter CL, Lange JS, Davis MG, Gerwe GS, Downs TR, Peters KG, Kasibhatla B.

Exp Biol Med (Maywood). 2005 Mar;230(3):207-16.

PMID:
15734724
12.

Germline PHOX2B mutation in hereditary neuroblastoma.

Mosse YP, Laudenslager M, Khazi D, Carlisle AJ, Winter CL, Rappaport E, Maris JM.

Am J Hum Genet. 2004 Oct;75(4):727-30. No abstract available.

13.

Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reaction.

Morowitz M, Shusterman S, Mosse Y, Hii G, Winter CL, Khazi D, Wang Q, King R, Maris JM.

Mod Pathol. 2003 Dec;16(12):1248-56.

14.

ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.

Wang Q, Hii G, Shusterman S, Mosse Y, Winter CL, Guo C, Zhao H, Rappaport E, Hogarty MD, Maris JM.

Cancer Res. 2003 Apr 1;63(7):1631-5.

15.

No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.

Hogarty MD, Winter CL, Liu X, Guo C, White PS, Look AT, Brodeur GM, Maris JM.

Cancer Res. 2002 Nov 15;62(22):6481-4.

16.

Dynamic control of an artificial neural system: the property inheritance network.

Ryan TW, Winter CL, Turner CJ.

Appl Opt. 1987 Dec 1;26(23):4961-71. doi: 10.1364/AO.26.004961.

PMID:
20523474

Supplemental Content

Loading ...
Support Center